Atlas Trials

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

Clinical trial NCT02066662 · COMPLETED

Trial details

NCT number
NCT02066662
Sponsor
RWTH Aachen University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial Fibrillation or Pulmonary EmbolismNeed of Long Term Oral Anticoagulation Therapy (OAT)Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
Start date
2013-07-01
Primary completion
2020-03-01
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.